Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bitopertin in Erythropoietic Protoporphyria
NCT05308472Phase 2Completed
- Sponsor
- Disc Medicine
- Start
- Oct 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bitopertin in erythropoietic protoporphyria (EPP), sponsored by Disc Medicine. Started Oct 2022; status: completed.
02
Drugs
bitopertin
03
Conditions
erythropoietic protoporphyria (EPP)
Beyond the preview
Go deeper on NCT05308472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05308472.